Your prediction
Pros and Cons of Accelerate Diagnostics Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Accelerate Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc. | - | - | - | - | - | - | - |
| MicroVision Inc | -3.420% | -2.983% | -2.263% | -45.262% | -48.555% | -63.238% | -85.633% |
| Fluidigm Corp. | -17.140% | 0.719% | 12.000% | -21.348% | -18.129% | 25.786% | -71.158% |
| Allscripts Healthcare | -5.560% | 0.000% | 0.000% | -57.647% | -57.647% | -78.443% | -68.696% |
Comments
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AXDX provided by MarketBeat
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AXDX provided by MarketBeat